Cleveland Medical Innovation Study Tour: Witness the Top 10 Medical Innovations of 2020 and Engage with Leading U.S. Health Tech Companies

With the launch of the “Healthy China” strategy, China’s healthcare industry is poised for a qualitative transformation. “Created in China” must leverage this fundamental shift to rise within the global healthcare sector. The United States, as a hub for leading-edge medical companies, boasts unparalleled advantages in cutting-edge technology and innovative management systems, offering valuable lessons for us to learn from.

From October 19 to 27 this year, VCBeat invites you to participate in the 9-day “2019 Cleveland Medical Innovation Summit and U.S. East Coast International Healthcare Investment Study Tour.” This program will take you to the forefront of American healthcare, offering insights into global developments in health economics, medical artificial intelligence, healthcare big data, and drug R&D, while exploring pathways for medical innovation with Chinese characteristics.

(Scan the QR code to register)

Spotting the Trend: Attend the World’s Top Healthcare Summit and Witness 2020Top 10 Medical Innovations Released

The highlight of this study tour was the in-depth participation in the 2019 Cleveland Clinic Medical Innovation Summit. Hosted by Cleveland Clinic, the Medical Innovation Summit is hailed as the world’s premier summit in the field of medical innovation. Now in its 16th year, it attracts prominent figures from global health systems, the medical academic community, and the investment sector.

The 2019 Healthcare Innovation Summit will focus on global discussions in healthcare innovation, bringing together over 2,000 attendees, more than 500 participating institutions, and 165+ speakers from 16+ countries. The summit features 40+ thematic sessions covering medical economics, artificial intelligence in medicine, healthcare big data, drug R&D, and more, showcasing groundbreaking new technologies in healthcare and health. Additionally, the Top 10 Healthcare Innovations for 2020 will be unveiled.

• Witness 2020Top Ten Medical Innovations of the Year Released: Exploring the Evolution of Artificial Intelligence and Drug Development

Annually, the center leads a panel of over 100 physicians and researchers from across the industry in selecting and publishing the Top Ten Medical Innovations for the upcoming year. Since its inception, this list has successfully predicted countless advances in immunotherapy, genomics, and cardiovascular medicine. By sharing the latest devices, technologies, topics, and treatment modalities, it provides guiding information to professionals across various fields of the healthcare community, exerting significant influence on the entire industry.

• Attend the medical technology lectures at top-tier summits, listen to 165+Insightful Sharing from Top Global Experts

Cleveland Clinic Innovations, as a world-leading medical institution, has hosted the Medical Innovation Summit every autumn for the past 16 years. This event is part of Cleveland Clinic’s commitment to advancing medical innovation and quality, attracting authoritative healthcare experts from around the globe.

The 2019 Summit, themed “The Evolution of Artificial Intelligence in Drug R&D,” featured over 40 sessions where attendees could learn about the diverse strategies leading companies and executives employ to seize opportunities in uncertain times. Renowned for its engaging one-on-one discussions with highly influential CEOs, the Innovation Summit offered a rich variety of formats, including “Face-to-Face Dialogues,” “Individual and Organizational Dialogues,” expert talks across various disciplines, panel discussions, workshops, as well as social events such as themed dinners and cocktail receptions. These activities facilitated in-depth exploration of how innovation and institutional reforms can foster a better healthcare environment.

• Global Investment Promotion Conference – China Session &AMP'D Roadshow Competition, In-depth exchanges with global innovative companies

The AMP'D Roadshow will feature 40 leading innovative startups in the healthcare sector, showcasing cutting-edge medical devices, health information technology, diagnostic solutions, and comprehensive healthcare services to a global audience. Winning projects will receive a $25,000 cash prize, exclusive media coverage, access to venture capital, and opportunities for dialogue with renowned physicians from Cleveland Clinic.

Learning from Experience: Visiting Tech Innovation Companies and Massachusetts General Hospital to Explore the Intersection of Technology and Medicine

• The Leader in High-End Imaging Diagnostic Products — Mingfeng R&D Center

Founded in 2011, the company has been dedicated to the research, development, and manufacturing of high-end medical imaging equipment. Within just four years, it successfully developed 16-slice spiral CT and PET/CT systems with independent intellectual property rights.

Headquartered in Shaoxing, Zhejiang Province, the company has established R&D and manufacturing centers in Dalian and Shanghai, China, as well as in Solon and Dayton, Ohio, USA. It boasts a team of renowned industry scientists and holds multiple world-leading patented technologies. Over the coming year, Mingfeng Medical will sequentially launch its high-end 128-slice spiral CT and 128-slice PET/CT systems. The company has also initiated R&D efforts for the state-of-the-art PET/MR, a premium diagnostic imaging product. Upon completion, Mingfeng Medical will achieve comprehensive coverage of high-end imaging products and join the ranks of top-tier international companies.

Over 80% of the company’s employees hold advanced degrees. The company holds multiple novel patented technologies, has been recognized as a “Zhejiang Province Leading Innovation Team for Introduction and Cultivation,” and operates the Mingfeng Nuclear Medicine Imaging Systems Research Institute, a provincial-level key enterprise research institute.

• The Dark Horse in the Navigation Market: US ST 3D Neurosurgical Navigation System Company

The company delivers unprecedented clarity and realism in 3D imaging, supporting multi-angle rotation to help physicians visualize critical blood vessels and neural tissues located behind lesions. During surgical navigation, physicians can also adjust tissue segmentation maps to highlight intracranial vasculature and surrounding tumors, particularly those displaced from their normal anatomical positions.

Furthermore, physicians can adjust relevant settings to enhance the transparency of tumors or accentuate surrounding blood vessels, thereby avoiding damage to critical functional tissues during actual surgical procedures. The ST system boasts prominent competitive advantages, featuring a clear and realistic image interface, refined 3D effects, and haptic feedback capabilities, while also achieving seamless integration with mainstream navigation devices currently available. It has received investment from Chuanrui International Technology Fund and HTC Taiwan.

• Massachusetts General Hospital: Home to World-Class Medical Resources and Renowned for Innovation

Massachusetts General Hospital, located in Boston, Massachusetts, is a long-established and large-scale teaching hospital affiliated with Harvard Medical School, and one of the three oldest hospitals in the United States. It has consistently ranked among the top hospitals in the U.S. News & World Report’s Best Hospitals rankings. Massachusetts General Hospital hosts the largest hospital-based research program in the nation, with annual research funding exceeding $850 million. The hospital is globally renowned for its leadership in cancer, cardiovascular disease, and neurological disorders. In particular, its Cancer Center is at the forefront of gene-targeted cancer therapies, proton beam therapy, and intraoperative radiation therapy. Over the years, Massachusetts General Hospital has achieved numerous medical breakthroughs, producing 13 Nobel laureates to date.

Exploring Collaboration: Visiting Two Major Industrial Parks to Connect Chinese and U.S. Resources in Pursuit of Innovative Partnerships

• The Bridge for Sino-US Sci-Tech Innovation Exchange — Zpark

Z-Park Zhongguancun Innovation Center is dedicated to building a bridge for scientific and technological innovation exchanges between China and the United States. The Zhongguancun Overseas Innovation Platform aggregates high-end innovation and entrepreneurship resources from North America, collaborating with numerous renowned investment funds, startup mentors, and academic experts to provide integrated professional services encompassing incubation acceleration, cross-border training, and analytical consulting. Zhongguancun assists American entrepreneurs and founders in exploring the Chinese market, while also supporting Chinese enterprises and investors in expanding their overseas operations through scientific, rational, and compliant international strategic planning.

Z-Park Boston Innovation Center is located in Cambridge, within the Greater Boston area of Massachusetts, adjacent to Harvard University and the Massachusetts Institute of Technology (MIT). By aggregating innovation and entrepreneurship resources in the Boston region and fostering collaboration among universities and enterprises, the Center builds an innovation ecosystem chain to serve the local entrepreneurial community. The facility features incubators, co-working spaces, private offices, event centers, and other multifunctional areas. It hosts over 200 technology analysis seminars, academic lectures, and venture capital events annually, attracting cutting-edge technologies and teams for incubation while serving as a soft-landing platform for Chinese companies seeking international exchange and market expansion. As a key hub, it promotes scientific and technological innovation exchanges and industrial development between China and the United States.

• The First High-Tech Park Co-Founded by China and the United States—Shanghai Zhangjiang Boston Biotech Park

The Shanghai Zhangjiang Boston Business Park is the first high-tech industrial park jointly established through Sino-U.S. cooperation. Located in Marlborough, a tranquil town in the Greater Boston area, it serves as one of the key hubs for biopharmaceutical companies in the United States. Renowned enterprises such as Boston Scientific, GE Healthcare, and Quest Diagnostics have established their presence here.

Guided by the mission of promoting joint scientific and technological innovation between China and the United States, the park has established platforms for joint R&D in cutting-edge fields, talent exchange, capital and market matchmaking, as well as a Biomedical Technology Innovation Center and a Medical Health Technology Innovation Center. Notably, Shanghai Baoteng Biomedical Technology Co., Ltd. has introduced two big data teams from Massachusetts General Hospital, affiliated with Harvard Medical School, to the park.

Innovation talent, technology, corporate, and capital resources from China and the United States will converge here, fostering extensive and in-depth cooperation between innovative enterprises in Shanghai and the broader region with their U.S. counterparts in technological innovation, market expansion, and capital operations. This will facilitate Chinese companies’ smooth entry into the U.S. and global markets. It will also enable zero-distance collaboration between U.S. innovative and manufacturing firms and Chinese enterprises, creating a fast track for U.S. businesses and technologies to access the Chinese market.

Reflections: A Brief Respite During the Study Tour, Appreciating the Trajectory of U.S. Medical Advancement and Urban Atmosphere

• Harvard University & Harvard Medical Museum

Located in Cambridge, within the Boston metropolitan area of Massachusetts, USA, it is a world-renowned private research university and a prestigious member of the Ivy League.

As of March 2018, eight Presidents of the United States, 157 Nobel laureates (ranked first worldwide), 18 Fields Medalists (ranked first worldwide), and 14 Turing Award winners (ranked fourth worldwide) had worked or studied here. The institution enjoys a prestigious academic standing and broad influence across multiple disciplines, including literature, medicine, law, and business, and is widely recognized as one of the world’s leading higher education institutions.

• Rock and Roll Hall of Fame

A Western rock music achievement award dedicated to honoring some of the most prominent and influential artists, producers, and individuals who have shaped the entire music industry through rock music in significant ways. Here, you will experience the collision of personality and art.

Fees Include:

1. Round-trip international airfare between Shanghai and the United States, plus domestic U.S. flights (economy class);

2. Visa fees for the destination country (excluding expedited visa processing fees);

3. Expenses for overseas business activities, training fees, and teaching material fees;

4. Professional translation fees for overseas business activities;

5. Meals listed in the overseas itinerary (excluding airport meals);

6. Professional Chinese-speaking tour guide services throughout the entire overseas trip;

7. First-entry tickets to the attractions listed in the itinerary;

8. Service charges and tips for overseas tour guides and drivers;

9. Overseas Individual Travel Insurance (covering only the duration of the trip and the destination country);

10. Professional tour leader services during the trip.

Exclusions:

1. This price does not include the cost of any nighttime tours for the group; if the group wishes to participate in nighttime tours, an additional service fee will be charged;

2. Excludes baggage handling fees and airport taxes;

3. Does not include airport baggage check-in fees;

4. Personal expenses incurred at the hotel;

5. Single room supplement: CNY 7,000.

Note: The actual tour organizer for this study tour is Lesu (Shanghai) Travel Agency Co., Ltd., and all travel services are provided by Lesu.

Sign Up by Scanning QR Code

Embark on a 9-Day, 7-Night In-Depth Journey into Medical Technology Innovation

Registration Deadline: September 15, 2019